ArticleJournal of advanced research2025

Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies.

Jie Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.